Omar Adwan Explains Antibody Detection with the HI Test
Omar Adwan, Medical Laboratory Technologist of Modawah lab center, shared a post on LinkedIn:
“Hemagglutination Inhibition (HI) Test:
1. Objective
To identify and measure antibodies that inhibit the ability of viruses to agglutinate red blood cells (RBCs)
2. Principle
Certain viruses (like Influenza) have surface proteins (hemagglutinins) that cause RBCs to clump together (hemagglutination).
If a patient’s serum contains specific antibodies, they will bind to the virus and block hemagglutination.
Thus, no agglutination = positive inhibition = antibodies present.
3. Materials
Patient serum sample
Viral antigen (e.g., Influenza virus)
Red blood cells (usually chicken, guinea pig, or human O-type)
Microtiter plates (V-bottom or U-bottom)
Phosphate buffered saline (PBS)
Micropipettes
4. Procedure
- Heat inactivate the patient serum (to remove non-specific inhibitors).
- Prepare serial dilutions of serum in microtiter plate wells.
- Add a constant amount of virus antigen to each well.
- Add a standardized suspension of RBCs.
- Incubate and observe results.
5. Results
Positive (Inhibition): A clear button of RBCs at the bottom of the well (no agglutination). Indicates presence of antibodies.
Negative (No Inhibition): RBCs form a diffuse lattice across the well (agglutination occurs). No antibodies present.
The HI titer is the highest serum dilution that completely inhibits hemagglutination.
6. Uses
Diagnosis of viral infections (e.g., Influenza, Measles, Mumps, Rubella).
Measurement of antibody titers after vaccination.
Surveillance of circulating viral strains.
7. Conclusion
The HI test is a simple, sensitive, and widely used method for detecting virus-specific antibodies and plays a key role in vaccine development and viral epidemiology.”

Stay updated with Hemostasis Today.
-
Nov 14, 2025, 11:58Marilena Vrana: Can Public-only Blood Collection Systems Meet the Growing Patient Need for PDMs?
-
Nov 14, 2025, 11:48Cedric Hermans Shares the 1st Illustrated Review Dedicated to Hemophilia B
-
Nov 14, 2025, 10:28Valance Washington: Proud to Share Our Lab’s Latest Publication in Platelets Journal
-
Nov 14, 2025, 10:18Sripal Bangalore and Ajay Kirtane on TUXEDO-2 Comparison Focusing on Diabetic Patients
-
Nov 14, 2025, 10:11Ashley Lawrenson on Her Coagulation Journey Using Automation With the HemoCell and HemoHub
-
Nov 14, 2025, 10:05Kingsley Wheaton: A Year Ago, Omni Was an Idea – Today, It’s a Movement!
-
Nov 14, 2025, 09:58Rucha Patil Takes The National DHR-ICMR Gold Award for Best Technology
-
Nov 14, 2025, 09:48Caitlin Raymond on ”The Plasma Chasers”
-
Nov 14, 2025, 09:42Erin VanDyke on Why They Do In-person Site Visits for NBCA Centers of Excellence Designation!
